Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PharmGKB summary: venlafaxine pathway.
Sangkuhl K, Stingl JC, Turpeinen M, Altman RB, Klein TE. Sangkuhl K, et al. Pharmacogenet Genomics. 2014 Jan;24(1):62-72. doi: 10.1097/FPC.0000000000000003. Pharmacogenet Genomics. 2014. PMID: 24128936 Free PMC article. Review. No abstract available.
Cytochrome P450 2D6.
Owen RP, Sangkuhl K, Klein TE, Altman RB. Owen RP, et al. Among authors: sangkuhl k. Pharmacogenet Genomics. 2009 Jul;19(7):559-62. doi: 10.1097/FPC.0b013e32832e0e97. Pharmacogenet Genomics. 2009. PMID: 19512959 Free PMC article. Review. No abstract available.
Selective serotonin reuptake inhibitors pathway.
Sangkuhl K, Klein TE, Altman RB. Sangkuhl K, et al. Pharmacogenet Genomics. 2009 Nov;19(11):907-9. doi: 10.1097/FPC.0b013e32833132cb. Pharmacogenet Genomics. 2009. PMID: 19741567 Free PMC article. No abstract available.
PharmGKB: very important pharmacogene--HMGCR.
Medina MW, Sangkuhl K, Klein TE, Altman RB. Medina MW, et al. Among authors: sangkuhl k. Pharmacogenet Genomics. 2011 Feb;21(2):98-101. doi: 10.1097/FPC.0b013e328336c81b. Pharmacogenet Genomics. 2011. PMID: 20084049 Free PMC article. No abstract available.
Cytochrome P450 2C9-CYP2C9.
Van Booven D, Marsh S, McLeod H, Carrillo MW, Sangkuhl K, Klein TE, Altman RB. Van Booven D, et al. Among authors: sangkuhl k. Pharmacogenet Genomics. 2010 Apr;20(4):277-81. doi: 10.1097/FPC.0b013e3283349e84. Pharmacogenet Genomics. 2010. PMID: 20150829 Free PMC article. Review. No abstract available.
Clinical assessment incorporating a personal genome.
Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, Dewey FE, Dudley JT, Ormond KE, Pavlovic A, Morgan AA, Pushkarev D, Neff NF, Hudgins L, Gong L, Hodges LM, Berlin DS, Thorn CF, Sangkuhl K, Hebert JM, Woon M, Sagreiya H, Whaley R, Knowles JW, Chou MF, Thakuria JV, Rosenbaum AM, Zaranek AW, Church GM, Greely HT, Quake SR, Altman RB. Ashley EA, et al. Among authors: sangkuhl k. Lancet. 2010 May 1;375(9725):1525-35. doi: 10.1016/S0140-6736(10)60452-7. Lancet. 2010. PMID: 20435227 Free PMC article.
Clopidogrel pathway.
Sangkuhl K, Klein TE, Altman RB. Sangkuhl K, et al. Pharmacogenet Genomics. 2010 Jul;20(7):463-5. doi: 10.1097/FPC.0b013e3283385420. Pharmacogenet Genomics. 2010. PMID: 20440227 Free PMC article. No abstract available.
PharmGKB summary: dopamine receptor D2.
Mi H, Thomas PD, Ring HZ, Jiang R, Sangkuhl K, Klein TE, Altman RB. Mi H, et al. Among authors: sangkuhl k. Pharmacogenet Genomics. 2011 Jun;21(6):350-6. doi: 10.1097/FPC.0b013e32833ee605. Pharmacogenet Genomics. 2011. PMID: 20736885 Free PMC article. No abstract available.
75 results